Stock OPTN OPTINOSE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus OptiNose, Inc.

Equities

OPTN

US68404V1008

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-02 pm EDT 		5-day change 1st Jan Change
1.04 USD -0.95% Intraday chart for OptiNose, Inc. +0.97% -19.38%
Jun. 27 Optinose Announces Expanded Access to XHANCE with Addition to National Commercial Formularies CI
May. 20 OptiNose, Inc. announced that it has received $4.68 million in funding CI

Evolution of the average Target Price on OptiNose, Inc.

Price target over the last 5 years

History of analyst recommendation changes

15d25c22558d7378e2843eda60295dc5.H_ImlkBc6B9qzfLnpLEEsfP28uAgzia5-sPJqIRJZ34.V6FX5y5po2sygaCMwOtX9oSOytBEoXLdlLWl0Oo-UAp5hWKkEGinfRn4yg~422f94270125294d53f3ca6deb074686

Analyst Recommendations on OptiNose, Inc.

Lake Street Adjusts Price Target on OptiNose to $4 From $3, Maintains Buy Rating MT
HC Wainwright Initiates OptiNose With Buy Rating, $5 Price Target MT
Lake Street Initiates OptiNose at Buy Rating With $3 Price Target MT
BMO Capital Adjusts Price Target on OptiNose to $5 From $6, Maintains Outperform Rating MT
Jefferies Assumes OptiNose at Buy with $5 Price Target MT
OPTINOSE : RBC Cuts Price Target on OptiNose to $10 From $17 on Lower Long-Term Sales Estimates; Outperform-Speculative Risk Rating Kept MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.04 USD
Average target price
3.75 USD
Spread / Average Target
+260.58%
High Price Target
5 USD
Spread / Highest target
+380.77%
Low Price Target
3 USD
Spread / Lowest Target
+188.46%

Consensus detail

Consensus revision (last 18 months)

Analysts covering OptiNose, Inc.

Lake Street
HC Wainwright
BMO Capital
Jefferies & Co.
RBC Capital Markets

Ratings for OptiNose, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. OPTN Stock
  4. Consensus OptiNose, Inc.